Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22730218 | 0.83 | MAPK1 (0.46) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL22730227 | 0.79 | MAPK1 (0.42) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL10692727 | 0.76 | MAPK1 (0.44) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL835731 | 0.74 | KCNN4 (0.42) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL9390382 | 0.74 | MAPK1 (0.43) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL22319094 | 0.72 | MAPK1 (0.41) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL3107619 | 0.72 | MAPK1 (0.46) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL5613335 | 0.70 | KCNN4 (0.39) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| SCHEMBL96177 | 0.69 | MAPK1 (0.55) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 | |
| Tert-Butylbenzene SCHEMBL18889 | 0.69 | MAPK1 (0.55) | MAPK1CYP2C19HIF1AALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1845078-B1 | PROCESS FOR PRODUCING LARGE CYCLIC KETONE AND INTERMEDIATE THEREFOR | TAKASAGO PERFUMERY CO LTD (JP) | 2017-06-07 | — | — | EP | claimed |
| EP-0974582-B1 | Process for the preparation of 4-substituted azetidinone derivatives | TAKASAGO PERFUMERY CO LTD (JP) | 2003-02-12 | — | — | EP | claimed |
| JP-4356505-A | — | — | None | — | — | JP | disclosed |
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-05-21 | — | — | US | disclosed |
| EP-2966054-B1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-01-02 | — | — | EP | disclosed |
| US-10029969-B2 | Method of producing optically-active aldehyde | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20170282169-A1 | ALUMINUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| EP-1845078-B1 | PROCESS FOR PRODUCING LARGE CYCLIC KETONE AND INTERMEDIATE THEREFOR | TAKASAGO PERFUMERY CO LTD (JP) | 2017-06-07 | — | — | EP | disclosed |
| EP-3153492-A1 | NOVEL COMPOUND AND FRAGRANCE COMPOSITION CONTAINING SAME | Takasago International Corporation (JP) | 2017-04-12 | — | — | EP | disclosed |
| US-20170088503-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION AND/OR FRAGRANCE COMPOSITION CONTAINING SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| US-20160152550-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2,3-DIHYDROFARNESAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-0632037-B1 | Process for the production of 4-substituted azetidinone derivatives | TANABE SEIYAKU CO (JP) | 1997-10-01 | — | — | EP | disclosed |
| EP-0646568-A2 | Tertiary butyl 4,4-bis(4'-hydroxyphenyl) pentanoate derivatives and positive resist materials containing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1995-04-05 | — | — | EP | disclosed |
| EP-0638552-A1 | PROCESS FOR SYNTHESIZING 4-SUBSTITUTED AZETIDINONE DERIVATIVE | SUNTORY LIMITED (JP) | 1995-02-15 | — | — | EP | disclosed |
| EP-0632037-A1 | Process for the production of 4-substituted azetidinone derivative | TANABE SEIYAKU CO., LTD. (JP) | 1995-01-04 | — | — | EP | disclosed |
| EP-0615163-A1 | Onium salts and positive resist materials using the same | Shin-Etsu Chemical Co., Ltd. (JP) | 1994-09-14 | — | — | EP | disclosed |
| EP-0573667-A1 | PROCESS FOR PRODUCING 4-SUBSTITUTED AZETIDINONE DERIVATIVE | NIPPON SODA CO., LTD. (JP) | 1993-12-15 | — | — | EP | disclosed |
| EP-0326640-B1 | (1R,5S,6S)-2-SUBSTITUTED THIO-6 (R)-1-HYDROXYETHYL -1-METHYL-CARBAPENEM - CARBOXYLIC ACID DERIVATIVES | LEDERLE (JAPAN) LTD. (JP) | 1993-04-28 | — | — | EP | disclosed |
| JP-H04356505-A | PRODUCTION OF POLY(HYDROXYSTYRENE) | SHIN ETSU CHEM CO LTD | 1992-12-10 | — | — | JP | disclosed |
| EP-0326640-A1 | (1R,5S,6S)-2-substituted thio-6 (R)-1-hydroxyethyl -1-methyl-carbapenem - carboxylic acid derivatives | LEDERLE (JAPAN) LTD. (JP) | 1989-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170282169-A1 | ALUMINUM CATALYST | ACSL6, ACSL3, HACL2 | MAPK1 3304/4885CYP2C19 1029/4885HIF1A 3146/4885 |
| US-10029969-B2 | Method of producing optically-active aldehyde | ALDH3A1, ALDH1A2, ADH1A | MAPK1 4176/4885CYP2C19 503/4885HIF1A 2714/4885 |
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | FZD7, TAS1R1, TAS2R5 | MAPK1 885/4885CYP2C19 1966/4885HIF1A 1315/4885 |
| US-20170088503-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION AND/OR FRAGRANCE COMPOSITION CONTAINING SAME | FZD7, TAS2R5, TAS2R40 | MAPK1 1675/4885CYP2C19 2603/4885HIF1A 1710/4885 |
| US-20160152550-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2,3-DIHYDROFARNESAL | FNTB, FNTA, LSS | MAPK1 1888/4885CYP2C19 1373/4885HIF1A 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.